SCHEMBL24312484

SCHEMBL24312484

NCc1ccccc1-c1ccncn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 3/20 0.46
▸ EGFR P00533 2/20 0.39
▸ CASP6 P55212 1/20 0.39
▸ MAPK14 Q16539 2/20 0.38
▸ LOXL2 Q9Y4K0 1/20 0.38
▸ MAPK10 P53779 1/20 0.38
▸ ATR Q13535 1/20 0.37
▸ HSP90AA1 P07900 1/20 0.36
▸ CYP46A1 Q9Y6A2 1/20 0.36
▸ AOC1 P19801 2/20 0.36
▸ AOC3 Q16853 2/20 0.36
▸ MAPK9 P45984 2/20 0.36
▸ MAPK13 O15264 1/20 0.36
▸ RAF1 P04049 1/20 0.36
▸ MAPK12 P53778 1/20 0.36
▸ MAPK11 Q15759 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ DCLK1 O15075 1/20 0.35
▸ PRKD3 O94806 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29473296 0.98 DPP4 (0.44) DPP4EGFRCASP6MAPK14LOXL2
SCHEMBL27908490 0.85 MAPK14 (0.37) DPP4EGFRCASP6MAPK14CYP1A2
Hydrochloric Acid SCHEMBL29723641 0.85 TAAR1 (0.39) DPP4EGFRCASP6LOXL2
Hydrochloric Acid SCHEMBL23498194 0.85 TAAR1 (0.39) DPP4EGFRCASP6LOXL2
SCHEMBL28144739 0.82 CASP6 (0.39) EGFRCASP6MAPK14MAPK10CYP46A1
SCHEMBL24312483 0.82 CYP2D6 (0.43) EGFRCASP6CYP46A1CYP1A2CYP2D6
SCHEMBL7503631 0.82 CASP6 (0.42) EGFRCASP6MAPK14ATRCYP46A1
SCHEMBL10601314 0.80 MAPK9 (0.43) EGFRCASP6MAPK14MAPK10HSP90AA1
SCHEMBL3790206 0.79 KDM4E (0.50) DPP4LOXL2ATRHSP90AA1CYP1A2
SCHEMBL29496884 0.79 KDM4E (0.50) DPP4LOXL2ATRHSP90AA1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220119395-A1 BICYCLIC COMPOUNDS ALIGOS THERAPEUTICS, INC. 2022-04-21 — — US disclosed
WO-2022081758-A1 BICYCLIC COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2022-04-21 — — WO disclosed
CN-103254241-B Organometallic complex, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LAB 2015-06-17 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119395-A1 BICYCLIC COMPOUNDS SLC10A1, PKD1, CYP11B2 DPP4 651/4885EGFR 2452/4885CASP6 2981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback